Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Tamoxifen × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 53 Carcinoma, Intraductal, Noninfiltrating 7 Breast Carcinoma In Situ 5 Neoplasms 3 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms, Male 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Multiple Endocrine Neoplasia Type 1 1 Inflammatory Breast Neoplasms 1 Infertility 1 Hyperglycemia 1 Glioblastoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 ERα+ Breast Cancer 1 Carcinoma, Lobular 1 Breast Cancer Subjects 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Bupivacaine 2 pyrotinib 1 exemestane 1 abemaciclib 1 Tumor Burden 1 Thioctic Acid 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Ropivacaine 1 Radiotherapy 1 Radiofrequency Ablation 1 Mastectomy 1 Mammaplasty 1 Letrozole 1 Drug Therapy 1 Dexmedetomidine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡